ASH 2023: MRD Highlights in BioPharma Drug Development

Read More

Association of Tumor Microenvironment T-Cell Repertoire and Mutational Load With Clinical Outcome After Sequential Checkpoint Blockade in Melanoma

Yusko et al.
Cancer Immunology Research
March 2019
Authors and Affiliates
Yusko E1, Vignali M1, Wilson RK2, Mardis ER2, Hodi FS3, Horak C4, Chang H4, Woods DM5, Robins H1,6, Weber J7 1 Adaptive Biotechnologies, Seattle, Washington. 2 McDonnell Genome Institute, Washington University in St. Louis, St. Louis, Missouri. 3 Dana-Farber Cancer Center, Boston, Massachusetts. 4 Bristol-Myers Squibb, Princeton, New Jersey. 5 Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center, New York, New York. 6 Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. 7 Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center, New York, New York.